United Orthopedic Corporation (TPEX:4129)

Taiwan · Delayed Price · Currency is TWD

90.90

0.00 (0.00%)

Jun 18, 2026, 1:30 PM CST

-12.17% (1Y)

Market Cap	8.77B -9.1%
Revenue (ttm)	5.85B +19.8%
Net Income	458.98M -17.0%
EPS	4.61 -19.7%
Shares Out	96.44M
PE Ratio	19.74
Forward PE	n/a
Dividend	4.50 (4.95%)
Ex-Dividend Date	Jul 23, 2025

Volume	179,832
Open	91.00
Previous Close	90.90
Day's Range	90.90 - 92.10
52-Week Range	86.80 - 131.50
Beta	0.37
Analysts	Strong Buy
Price Target	123.67 (+36.05%)
Earnings Date	Aug 12, 2026

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee joints, including artificial knee replacement joints, revision knee replacement systems, restricted artificial knee joints, and customized artificia... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1993

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 4129

Full Company Profile

Financial Performance

In 2025, United Orthopedic's revenue was 5.66 billion, an increase of 21.54% compared to the previous year's 4.65 billion. Earnings were 562.02 million, an increase of 23.14%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 4129 stock is "Strong Buy." The 12-month stock price target is $123.67, which is an increase of 36.05% from the latest price.

Price Target

$123.67

(36.05% upside)

Analyst Consensus: Strong Buy

Stock Forecasts